Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Anstead

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Microbiology|May 6, 2011
Lack of association of small-colony-variant Staphylococcus aureus strains with long-term use of azithromycin in patients with cystic fibrosisNicole Green, Jane L Burns, Nicole Mayer-Hamblett, et al.
Pediatric Pulmonology|May 9, 2019
Patients and families experience with pharmacist care at cystic fibrosis foundation accredited clinicsDavid C Young, Elizabeth Autry, Jeffery T Zobell, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 14, 2013
Pulmonary exacerbations in CF patients with early lung diseaseMichael Anstead, Lisa Saiman, Nicole Mayer-Hamblett, et al.
Chest|May 19, 2012
Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosaFelix Ratjen, Lisa Saiman, Nicole Mayer-Hamblett, et al.
Pediatric Pulmonology|June 12, 2012
Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosaLisa Saiman, Nicole Mayer-Hamblett, Michael Anstead, et al.
Respiratory Research|February 22, 2023
Predictors and outcomes of acute pulmonary embolism in COVID-19; insights from US National COVID cohort collaborativeMuhammad H Gul, Zin Mar Htun, Vinicio de Jesus Perez, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 5, 2012
Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trialMichael Anstead, Sonya L Heltshe, Umer Khan, et al.
JAMA|May 6, 2010
Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trialLisa Saiman, Michael Anstead, Nicole Mayer-Hamblett, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 17, 2014
Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in children with cystic fibrosisCori Daines, Donald VanDeVanter, Umer Khan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 7, 2023
Position paper: Models of post-transplant care for individuals with cystic fibrosisEdward McKone, Kathleen J Ramos, Cecilia Chaparro, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Microbiology|May 6, 2011
Lack of association of small-colony-variant Staphylococcus aureus strains with long-term use of azithromycin in patients with cystic fibrosisNicole Green, Jane L Burns, Nicole Mayer-Hamblett, et al.
Pediatric Pulmonology|May 9, 2019
Patients and families experience with pharmacist care at cystic fibrosis foundation accredited clinicsDavid C Young, Elizabeth Autry, Jeffery T Zobell, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 14, 2013
Pulmonary exacerbations in CF patients with early lung diseaseMichael Anstead, Lisa Saiman, Nicole Mayer-Hamblett, et al.
Chest|May 19, 2012
Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosaFelix Ratjen, Lisa Saiman, Nicole Mayer-Hamblett, et al.
Pediatric Pulmonology|June 12, 2012
Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosaLisa Saiman, Nicole Mayer-Hamblett, Michael Anstead, et al.
Respiratory Research|February 22, 2023
Predictors and outcomes of acute pulmonary embolism in COVID-19; insights from US National COVID cohort collaborativeMuhammad H Gul, Zin Mar Htun, Vinicio de Jesus Perez, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 5, 2012
Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trialMichael Anstead, Sonya L Heltshe, Umer Khan, et al.
JAMA|May 6, 2010
Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trialLisa Saiman, Michael Anstead, Nicole Mayer-Hamblett, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 17, 2014
Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in children with cystic fibrosisCori Daines, Donald VanDeVanter, Umer Khan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 7, 2023
Position paper: Models of post-transplant care for individuals with cystic fibrosisEdward McKone, Kathleen J Ramos, Cecilia Chaparro, et al.
Pageof 2